Spinal Deformity Intraoperative Monitoring.
SDIM: Spinal Deformity Intraoperative Monitoring. Understanding and Managing Intraoperative Neuromonitoring Changes During Spinal Deformity Surgery: a Prospective Interventional Study
1 other identifier
interventional
569
14 countries
24
Brief Summary
A multicenter, international prospectively collected patient cohort undergoing high-risk spinal cord level surgery or spinal osteotomy procedures will be enrolled to establish the incidence of intraoperative alerts in high-risk spinal cord cases, and explore factors associated with mitigating injury. Baseline, intraoperative, and postoperative characteristics, including demographics, radiological features, lower extremity motor score (LEMS), procedure, anesthetic agents used, and baseline blood pressure will be recorded for either adult patients or pediatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Longer than P75 for not_applicable
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 19, 2019
CompletedStudy Start
First participant enrolled
May 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedNovember 21, 2022
November 1, 2022
2.9 years
March 13, 2019
November 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of intraoperative neuromontoring alerts
Number of intraoperative neuromonitoring alert, defined as a major change in neuromonitoring signals: * SSEP: amplitude loss \> 50% * MEP: amplitude loss \> 50% in two of three muscle groups and/or * EMG: sustained activity for \> 10 seconds
Intraoperative
Secondary Outcomes (4)
Intraoperative monitoring alert
Intraoperative
Success rate of reversal maneuvers to restore signal above the threshold
Intraoperative
Neurological status
Baseline up to 30 days postoperative
Timing of intraoperative monitoring alerts
Intraoperative
Study Arms (1)
Intraoperative Maneuvers
OTHERTo document intraoperative maneuvers performed in repsonse to alerts
Interventions
Monitoring procedure during surgery
Eligibility Criteria
You may qualify if:
- Age \>10 years to \<80 years
- Neurologically intact spinal cord (with or without radiculopathy)
- Undergoing primary or revision procedure in the spine
- Anterior and/or posterior surgical approach for any of the following:
- Correction of spinal deformity with a major Cobb angle of ≥ 80° in the coronal or sagittal plane
- Correction of high grade spondylolisthesis (Grades 3- 5)
- Posterior column or 3-column osteotomy
- Requiring multimodal neuromonitoring with EMG, SSEP, and MEP as per standard of care
- Informed consent obtained for patients i.e.:
- Ability to understand the content of the patient information
- Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
- Signed and dated EC/IRB approved written informed consent OR
- Written consent obtained according to defined and IRB/EC approved procedures for patients who are not able to provide independent written informed consent
You may not qualify if:
- Upper motor neuron lesion
- Growing rods or growth guidance procedures
- Tether or staple procedures
- Stand-alone cervical deformity correction procedures
- Any not medically managed severe systemic disease
- Recent history of substance abuse (ie recreational drugs, alcohol) that would preclude reliable assessment
- Pregnancy or women planning to conceive within the study period
- Prisoner
- Participation in any other medical device or medicinal product study that could influence the results of the present study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (24)
UC San Franciisco
San Francisco, California, 94143, United States
University of Minnesota
Minneapolis, Minnesota, 55454, United States
Columbia University Medical Center
New York, New York, 10032, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
University of Virginia
Charlottesville, Virginia, 22904, United States
Royal North Shore Hospital
Saint Leonards, 2065, Australia
Hospital Infantil Joana de Gusmão
Florianópolis, 88025, Brazil
Hospital das clinicas de São Paulo e AACD
São Paulo, Brazil
Shriners Hospital for Children
Montreal, 124001, Canada
Montreal General Hospital
Montreal, Canada
Toronto Western Hospital
Toronto, M5T 2S8, Canada
Nanjing Drum Tower Hospital
Nanjing, 210008, China
Queen Mary Hospital
Hong Kong, Hong Kong
Mallika Spine Centre
Guntur, 522001, India
Kothari Medical Centre
Kolkata, 700027, India
Tel Aviv Medical Center - Dana Children's Hospital
Tel Aviv, Israel
Hamamatsu University School of Medicine
Hamamatsu, Japan
University Medical Center St. Radboud
Nijmegen, Netherlands
Ghurki Trust Teaching Hospital
Lahore, Pakistan
Hospital Vall d'Helbron
Barcelona, 08035, Spain
Acibadem Maslak Hospital
Istanbul, 34457, Turkey (Türkiye)
Guys Hospital
London, United Kingdom
Salford Royal Hospital
Manchester, United Kingdom
Nottingham Queens Medical Centre
Nottingham, NG7 2UH, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2019
First Posted
March 19, 2019
Study Start
May 15, 2019
Primary Completion
March 31, 2022
Study Completion
November 1, 2022
Last Updated
November 21, 2022
Record last verified: 2022-11